Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

4/2/25 4:05:00 PM ET

Medical/Dental Instruments

Health Care

Get the next $KMTS alert in real time by email

KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.

A live and archived webcast of the conference call will be available in the "Events" section of the investor relations website. Participants are encouraged to register on the website at least 10 minutes prior to the start of the conference call.

About Kestra

Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact
Neil Bhalodkar
[email protected]

Get the next $KMTS alert in real time by email

Date	Price Target	Rating	Analyst
3/31/2025	$30.00	Buy	BofA Securities
3/31/2025	$29.00	Outperform	Wolfe Research
3/31/2025	$24.00	Neutral	Goldman
3/31/2025	$28.00	Buy	Stifel
3/31/2025	$28.00	Overweight	Wells Fargo
3/31/2025	$27.00	Overweight	Piper Sandler

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

Chat with this insight

Recent Analyst Ratings for
$KMTS

$KMTS
Press Releases

Fastest customizable press release news feed in the world

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

$KMTS
Leadership Updates

Live Leadership Updates

Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors

$KMTS
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

BofA Securities initiated coverage on Kestra Medical Technologies with a new price target

Wolfe Research initiated coverage on Kestra Medical Technologies with a new price target

Goldman initiated coverage on Kestra Medical Technologies with a new price target

$KMTS
Financials

Live finance-specific insights